VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Ermium Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 25 out of 100

  • Biotech & therapeutics
Status
Shut downas of 2026-09-17Source (opens in a new tab)
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Ermium Therapeutics is a biotech company developing functionally selective immunomodulators targeting CXCR4 for auto-immune disease indications, particularly interferonopathies, including SLE. The company ceased operations in 2024.

About the company

Status notes
The company ceased operations in 2024.
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy